Senate Majority Leader John Thune Moves to Advance Crypto Clarity Act 
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico 
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales 
ICE to Complete Nationwide Body Camera Rollout by End of August 
Trump Orders Warning Signs Outside Smithsonian Museum Over ‘Anti-American’ Exhibits 
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 
NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead 
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions 
Trump Orders Probe Into Pentagon Munitions Stockpile Leaks After Iran Conflict 
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest 
France Keeps Top Health Alert as Officials Brace for Another Heatwave 
SEC Moves to Dismiss Insider Trading Case Against Trump-Pardoned Terren Peizer 
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations 
AI Data Center Boom Faces New Risks as Public Backlash and Policy Scrutiny Grow 
FDA Pilot Program Eases Rules for Nicotine Pouch Makers 
Trump Administration Weighs Executive Order on Vaccines and Autism Research 
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations 
U.S. President Donald Trump has signed an executive order aimed at expanding the use of artificial intelligence (AI) in pediatric cancer research. The order provides an additional $50 million in research grants to accelerate progress in finding cures for childhood cancers, according to White House officials.
This move builds on the National Cancer Institute’s (NCI) Childhood Cancer Data Initiative, a decade-long, $500 million program launched in 2019 to collect and share vital data on pediatric cancers. Michael Kratsios, director of the White House Office of Science and Technology Policy, highlighted that childhood cancer remains the leading cause of disease-related deaths among children in the United States, with cases rising more than 40% since 1975.
Kratsios noted that advances in AI can now be harnessed to sharpen diagnoses, improve clinical trials, fine-tune treatment strategies, and enhance prevention methods. Data gathered through the NCI initiative is expected to empower researchers with new tools to tackle the complexity and diversity of pediatric cancers.
In addition to the $50 million in grants, the National Institutes of Health (NIH) will double its commitment by investing another $50 million. This funding aims to attract leading scientific teams through competitive research opportunities. Further investments are also anticipated to strengthen ongoing initiatives.
The announcement comes despite Trump’s 2026 budget proposal, which suggested a 37% cut to the NCI budget. Lawmakers in both the House and Senate, however, have pushed back against these cuts, and budget negotiations remain ongoing.
Globally, the World Health Organization reports that around 400,000 children and adolescents are diagnosed with cancer each year. While advances in adult cancer research have surged with AI, pediatric cancer research has lagged due to challenges like cancer rarity, diversity, and ethical concerns over patient data protection.
By reinforcing funding and leveraging AI, the administration aims to close this gap and accelerate life-saving innovations in childhood cancer treatment.
